Trial intelligence / Profile preview

DSXS HPA Axis Suppression in Atopic Dermatitis

NCT02595008Phase 2Completed

Start
Aug 2015
Primary completion
Feb 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of desoximetasone in atopic dermatitis (AD). Started Aug 2015; status: completed.

02

Drugs

desoximetasone
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT02595008.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02595008.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call